Poly Medicure closes trading window ahead of Q2FY27 results

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026
  • Closure lasts until 48 hours after Q2FY27 results declaration
  • Compliance with SEBI insider trading regulations cited
  • Board meeting date for results to be announced later
powered bylight_fuzz_icon
52153186

*this image is generated using AI for illustrative purposes only.

Poly Medicure Limited has closed its trading window for designated persons starting October 1, 2026. The closure will remain in effect until 48 hours after the declaration of financial results for the quarter and half-year ended September 30, 2026.

Regulatory Compliance

The company stated that this action complies with the SEBI (Prohibition to Insider Trading) Regulations, 2015, as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018. The decision also adheres to clarifications provided by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated April 2, 2019, and NSE letter ref no: NSE/CML/2019/11 dated April 2, 2019.

Additionally, the closure follows the company's Code of Conduct for prevention of insider trading. The move ensures that designated persons do not trade in the company's securities while in possession of unpublished price-sensitive information regarding the upcoming quarterly results.

Board Meeting Schedule

The date of the Board Meeting to consider and approve the financial results for the period ending September 30, 2026, will be intimated to the stock exchanges in due course. The company notified BSE Limited and National Stock Exchange of India Limited of this development on September 28, 2026.

Historical Stock Returns for Poly Medicure

1 Day5 Days1 Month6 Months1 Year5 Years
-2.02%-5.02%-5.37%+37.69%-15.82%+76.89%

How might the upcoming Q2 FY27 results influence Poly Medicure's valuation multiples given recent trends in the medical device sector?

What specific product segments within Poly Medicure's portfolio are expected to drive revenue growth in the current quarter?

How will the company's international expansion strategy impact its margin profile in the coming fiscal year?

Poly Medicure schedules investor meet with Avendus Spark on Sept 30

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Poly Medicure Limited to meet Avendus Spark on September 30, 2026
  • Meeting scheduled for 10:00 am at Ballabgarh plant in Haryana
  • Interaction is a one-on-one format including a plant visit
  • No unpublished price sensitive information will be disclosed
powered bylight_fuzz_icon
51797735

*this image is generated using AI for illustrative purposes only.

Poly Medicure Limited will host a one-on-one meeting with analysts and investors from Avendus Spark on September 30, 2026. The session is scheduled for 10:00 am at the company's facility in Ballabgarh, Haryana.

The meeting involves a plant visit at the company's industrial area location in Faridabad. This interaction is part of the company's regular engagement with institutional investors and analysts.

Meeting Details

Participant Date Time Venue Format
Avendus Spark September 30, 2026 10:00 am Plant Visit, Ballabgarh, Haryana One-on-one

Regulatory Compliance

The company stated that no unpublished price sensitive information (UPSI) will be shared during the meeting. The schedule is subject to change due to exigencies on the part of the analysts, investors, or the company.

This intimation was filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details are also available on the company's official website.

Historical Stock Returns for Poly Medicure

1 Day5 Days1 Month6 Months1 Year5 Years
-2.02%-5.02%-5.37%+37.69%-15.82%+76.89%

How might the insights shared during the Avendus Spark meeting influence Poly Medicure's stock valuation in the upcoming quarter?

What specific operational efficiencies or capacity expansions at the Ballabgarh facility are analysts expected to scrutinize during the plant visit?

Will the engagement with Avendus Spark lead to revised earnings estimates or target price adjustments from other institutional investors?

More News on Poly Medicure

1 Year Returns:-15.82%